"Unnamed: 0","ID","Description","GeneRatio","BgRatio","pvalue","p.adjust","qvalue","geneID","Count"
"R-HSA-6798695","R-HSA-6798695","Neutrophil degranulation","6/24","482/10891",0.000495760098919479,0.0344446689253567,0.0189169806455048,"PRCP/GM2A/CTSH/CTSZ/ATP6V1D/CRISP3",6
"R-HSA-2219530","R-HSA-2219530","Constitutive Signaling by Aberrant PI3K in Cancer","3/24","78/10891",0.000641826129043913,0.0344446689253567,0.0189169806455048,"CD80/FGF9/FLT3LG",3
"R-HSA-74752","R-HSA-74752","Signaling by Insulin receptor","3/24","78/10891",0.000641826129043913,0.0344446689253567,0.0189169806455048,"FGF9/ATP6V1D/FLT3LG",3
"R-HSA-2219528","R-HSA-2219528","PI3K/AKT Signaling in Cancer","3/24","104/10891",0.00147972184603723,0.0423846815143246,0.0232776282916199,"CD80/FGF9/FLT3LG",3
"R-HSA-6811558","R-HSA-6811558","PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling","3/24","106/10891",0.00156308935286133,0.0423846815143246,0.0232776282916199,"CD80/FGF9/FLT3LG",3
"R-HSA-912526","R-HSA-912526","Interleukin receptor SHC signaling","2/24","27/10891",0.00157955334835992,0.0423846815143246,0.0232776282916199,"IL2RA/IL5RA",2
"R-HSA-199418","R-HSA-199418","Negative regulation of the PI3K/AKT network","3/24","113/10891",0.0018779591936228,0.0431930614533243,0.0237215898141827,"CD80/FGF9/FLT3LG",3
